Abstract
Refine processes to accelerate and improve clinical trials
Executing a successful clinical trial requires seamless communication and
coordination among many stakeholders- study sponsors, contract research
organizations, academic research organizations, site management organizations,
patient recruiters, clinical investigators and patients.
Research shows that there is much room for improvement. The average Phase 1,
2, and 3 trials exceed their timelines by 20%. Delays in the clinical trial
process cost pharma companies hundreds of thousands - even millions - in
sales. Today, companies also encounter formidable challenges in the clinical
development process, including the FDA' s increased involvement.
Streamlining Clinical Trials is the authoritative tool for clinical operations
teams to accelerate their trials. This comprehensive guide delves into the
latest industry trends and strategies for elevating efficiency. It focuses on
resource allocation, performance measurement, continuous process
improvement, patient and investigator recruitment and adaptive trial
designs. Through extensive benchmarking data, real-company case studies
and interviews with industry experts, the report shows how companies are
moving their product candidates through development faster and more
efficiently.
Use the report to:
- Benchmark your clinical operations against leading companies
- Clarify performance objectives
- Identify and eliminate common trial bottlenecks
- Drive successful patient recruitment campaigns
- Plan study design and protocol effectively
- Discover and apply innovative patient and investigator retention strategies
- Weigh the pros and cons of adaptive trial designs versus traditional trials
Companies Included in Report
- Abbott Labs
- Allergan
- Amgen
- AstraZeneca
- Baxter Healthcare
- Bristol-Myers Squibb
- Covance
- Cephalon
- CSP
- EmpiriStat
- Genzyme
- Gilead Sciences
- Medarex
- Merck
- Millennium Pharmaceuticals
- Neurogen
- Nycomed
- Onyx Pharmaceuticals
- Ortho-McNeil Janssen
- PDL Biopharma
- Pfizer
- Pharma Consulting Solutions
- PPD
- ResearchLink
- Sanofi-Aventis
- Schering-Plough
- Teva
- UCB Pharmaceuticals